alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE>                                            5
<MULTIPLIER>                                     1,000
       
<S>                                        <C>
<PERIOD-TYPE>                                     YEAR
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                           3,443
<SECURITIES>                                         0
<RECEIVABLES>                                    6,999<F1>
<ALLOWANCES>                                       599
<INVENTORY>                                      3,649
<CURRENT-ASSETS>                                15,435
<PP&E>                                           9,259<F1>
<DEPRECIATION>                                   7,529
<TOTAL-ASSETS>                                  17,820
<CURRENT-LIABILITIES>                            5,499
<BONDS>                                          1,245
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           100
<OTHER-SE>                                      10,976
<TOTAL-LIABILITY-AND-EQUITY>                    17,820
<SALES>                                         41,317
<TOTAL-REVENUES>                                41,317
<CGS>                                           26,379
<TOTAL-COSTS>                                   26,379
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   136
<INTEREST-EXPENSE>                                 148
<INCOME-PRETAX>                                (2,161)
<INCOME-TAX>                                       184
<INCOME-CONTINUING>                            (1,977)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,977)
<EPS-PRIMARY>                                   (0.46)
<EPS-DILUTED>                                   (0.46)
<FN>
<F1>Presented gross
</FN>
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM PART 1 ITEM
1 OF THE COMPANY'S 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          67,818
<SECURITIES>                                         0
<RECEIVABLES>                                   14,982
<ALLOWANCES>                                     1,134
<INVENTORY>                                          0
<CURRENT-ASSETS>                                85,130
<PP&E>                                           5,164
<DEPRECIATION>                                   1,804
<TOTAL-ASSETS>                                  92,158
<CURRENT-LIABILITIES>                           12,915
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           258
<OTHER-SE>                                      78,591
<TOTAL-LIABILITY-AND-EQUITY>                    92,158
<SALES>                                              0
<TOTAL-REVENUES>                                30,027
<CGS>                                                0
<TOTAL-COSTS>                                    4,560
<OTHER-EXPENSES>                                24,147
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 617
<INCOME-PRETAX>                                  3,056
<INCOME-TAX>                                       343
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,713
<EPS-BASIC>                                       0.12
<EPS-DILUTED>                                     0.10





</TABLE>
Pursuant to 5 T H C IR . R. 47.5, the court has determined that thi s opinio n should not * be publishe d an d is not precedent except under the limited circu mstance s set forth in 5 T H C IR . R. 47.5 .4. 

### INTHE UNI TED S TATESCOU RT OFAPPEALS

FORTHE FIFTH CIRCU IT

N o. 06- 60193 Su m m ar y Cal endar DANI EL GI RM AI NEGUSI E, P et i t i on er v. ERI C H . HO LDER , J R. , U. S. ATTORN EY GE N ERA L, Res po nde nt

O n R em an d f

rom t h e Su prem e C ou rtof t h e U n i t ed S t ates (A 15 575 924) B ef ore K IN G , H IG G IN B O T H M , an d G A R Z A , C i rcui tJu dg es . P E R C U R I A M: * I n Negusi e v. Hol d er , 555 U . S . ___ ( 200 9) , t h e Su prem e C ou rtof t h e U n i t ed St at e s r e ve r s e d o urj udg m e nti n t hi s ca s e , w hi c h af f i r m e d t he j udg m e nto f t he Boar d o f

I m m i gr at i o n A ppe al s . The Cour tre m and e d w i t h i ns t r uc t i o ns fo rt he B oa rd to i n terp ret th e relev a n t sta tu te, 8 U . S . C . § 1 1 0 1 (a)( 4 2 ), con sist en t w i th its o p in io n . T h e ju d g m e n t o f th e B o a r dis th e r e fo r e VA C A T E D , a n dth e ca s e is r e m and e d t o i tf

o rf ur t he rpr o c e e di ngs c o ns i s t e ntw i t h t he Cour t ’ s o pi ni o n. VA CA T ED . United States Court of App eals Fifth Circuit 

### F I L E D April13, 2009 Cha rl es R. F ulb ru g e II I Clerk
-)

Tonto National Forest Legend

Supervisor's Office (treatment Pr
UTM Zone 12 NAD83

6 Feb 2010
t | 0 : 0.2

~ Miles
In The 

Court of Appeals 

Seventh District of Texas at Amarillo

No. 07-15-00136-CV 

GREG NOYOLA, APPELLANT 

 

V. 

 

TITLE ONE, DIGITAL TITLE SERVICES, LLC AND BRADLEY ELDER, 

INDIVIDUALLY, APPELLEES 

 

On Appeal from the 237th District Court 

Lubbock County, Texas 

Trial Court No. 2014-514,028, Honorable Leslie Hatch, Presiding 

 

July 10, 2015 

 

MEMORANDUM OPINION 

 

Before QUINN, C.J., and HANCOCK and PIRTLE, JJ. 

Through their attorneys, Greg Noyola, appellant, and Title One, Digital Title 

Services, LLC and Bradley Elder, appellees, have filed a joint motion to voluntarily 

dismiss the appeal. Without passing on the merits of the case, we grant the motion 

pursuant to Texas Rule of Appellate Procedure 42.1(a) and dismiss the appeal. Having 

dismissed the appeal at the parties’ request, no motion for rehearing will be entertained, 

and our mandate will issue forthwith. 

Per Curiam
### §430g–8. Advisory Commission

#### (a) Establishment

There is hereby established the Gettysburg National Military Park Advisory Commission (hereafter in sections 430g–8 to 430g–10 of this title referred to as the "Advisory Commission"). The Advisory Commission shall be composed of eleven members, as follows:

(1) One member representing each of the local governments from the four townships surrounding the park and the Borough of Gettysburg, appointed by the Secretary.

(2) One member representing the Adams County, Pennsylvania government, appointed by the Secretary.

(3) One member representing the State Historic Preservation Office of the State of Pennsylvania, appointed by the Secretary.

(4) Two members who are residents of Adams County and who are knowledgeable about the park and its resources, appointed by the Secretary, one of whom shall own land or interests in land within the park boundary.

(5) One member with expertise in local historic preservation, appointed by the Secretary.

(6) The Director of the National Park Service or his designee, ex officio.

Members shall be appointed for staggered terms of three years, as designated by the Secretary at the time of the initial appointments. Any member of the Advisory Commission appointed for a definite term may serve after the expiration of his term until his successor is appointed. The Advisory Commission shall designate one of its members as Chairperson. Six members of the Advisory Commission shall constitute a quorum.

#### (b) Management and development issues

The Secretary, or his designee, shall from time to time, but at least semiannually, meet and consult with the Advisory Commission to coordinate the management of the park and the historic district with local jurisdictions.

#### (c) Meetings

The Advisory Commission shall meet on a regular basis. Notice of meetings and agenda shall be published in local newspapers which have a distribution which generally covers the area affected by the park. Advisory Commission meetings shall be held at locations and in such a manner as to ensure adequate public involvement.

#### (d) Expenses

Members of the Advisory Commission shall serve without compensation as such, but the Secretary may pay expenses reasonably incurred in carrying out their responsibilities under sections 430g–4 to 430g–10 of this title on vouchers signed by the Chairperson.

#### (e) Charter

The provisions of section 1013 of title 5 are hereby waived with respect to this Advisory Commission.

(Pub. L. 101–377, §5, Aug. 17, 1990, 104 Stat. 466; Pub. L. 117–286, §4(a)(90), Dec. 27, 2022, 136 Stat. 4315.)

#### **Editorial Notes**

#### Amendments

2022—Subsec. (e). Pub. L. 117–286 substituted "section 1013 of title 5" for "section 14 of the Federal Advisory Committee Act (5 U.S.C. App.)".
SECURITIES AND EXCHANGE COMMISSION

Investment Company Act Release No. 35154; 812-15546

Felicitas Private Markets Fund and Skypoint Capital Advisors, LLC

March 15, 2024

AGENCY: Securities and Exchange Commission (“Commission” or “SEC”).

ACTION: Notice.

Notice of an application under section 6(c) of the Investment Company Act of 1940 (the “Act”) 

for an exemption from sections 18(a)(2), 18(c) and 18(i) of the Act and for an order pursuant to 

section 17(d) of the Act and rule 17d-1 under the Act.

Summary of Application: Applicants request an order to permit certain registered closed-end 

investment companies to issue multiple classes of shares of beneficial interest with varying sales 

loads and to impose asset-based distribution and/or service fees.

Applicants: Felicitas Private Markets Fund and Skypoint Capital Advisors, LLC

Filing Dates: The application was filed on February 1, 2024.

Hearing or Notification of Hearing: An order granting the requested relief will be issued unless 

the Commission orders a hearing. Interested persons may request a hearing on any application 

by e-mailing the SEC’s Secretary at Secretarys-Office@sec.gov and serving the Applicants with 

a copy of the request by e-mail, if an e-mail address is listed for the relevant Applicant below, or 

personally or by mail, if a physical address is listed for the relevant Applicant below. Hearing 

requests should be received by the Commission by 5:30 p.m. on April 9, 2024, and should be 

accompanied by proof of service on the Applicants, in the form of an affidavit, or, for lawyers, a 

certificate of service. Pursuant to rule 0-5 under the Act, hearing requests should state the nature 

of the writer’s interest, any facts bearing upon the desirability of a hearing on the matter, the 
reason for the request, and the issues contested. Persons who wish to be notified of a hearing 

may request notification by emailing the Commission’s Secretary. 

ADDRESSES: The Commission: Secretarys-Office@sec.gov. Applicants: Joshua B. Deringer, 

Esq., Faegre Drinker Biddle & Reath LLP, joshua.deringer@faegredrinker.com, Veena K. Jain, 

Faegre Drinker Biddle & Reath LLP, veena.jain@faegredrinker.com, with a copy to Brian 

Smith, Skypoint Capital Advisors, LLC, bsmith@skypointfunds.com. 

FOR FURTHER INFORMATION CONTACT: Trace W. Rakestraw, Senior Special Counsel, at 

(202) 551-6825 (Division of Investment Management, Chief Counsel’s Office).

SUPPLEMENTARY INFORMATION: For Applicants’ representations, legal analysis, and 

conditions, please refer to Applicants’ application, filed February 1, 2024, which may be 

obtained via the Commission’s website by searching for the file number at the top of this 

document, or for an Applicant using the Company name search field on the SEC’s EDGAR 

system. The SEC’s EDGAR system may be searched at 

https://www.sec.gov/edgar/searchedgar/legacy/companysearch.html. You may also call the 

SEC’s Public Reference Room at (202) 551-8090.

For the Commission, by the Division of Investment Management, under delegated 

authority.

Sherry R. Haywood,

Assistant Secretary.
CS 314937-P 04/24/2020

cdc.gov/coronavirus

Ce que vous devriez savoir à propos du COVID-19 pour 

vous protéger et protéger les autres

Connaître le COVID-19

• Le coronavirus (COVID-19) est une maladie 

provoquée par un virus pouvant se propager 

d’une personne à l’autre.

• Le virus provoquant le COVID-19 est un 

coronavirus nouveau qui s’est propagé à travers 

le monde. 

• Les symptômes de COVID-19 peuvent être 

modérés (ou absents) ou graves.

Comment le COVID-19 se propage-t-il ?

• Vous pouvez être infecté(e) en étant à 

proximité (à distance de 2 mètres ou de 

deux bras environ) d’une personne atteinte 

du COVID-19. Le COVID-19 se propage 

essentiellement d’une personne à l’autre.

• Vous pouvez devenir infecté(e) en respirant les 

fines gouttes émises par une personne infectée 

qui tousse, éternue ou parle.

• Vous pouvez aussi contracter le virus en 

touchant une surface ou un objet contaminé, 

puis en vous touchant la bouche, le nez ou 

les yeux.

Se protéger et protéger les autres du COVID-19

• Il n’existe aujourd’hui aucun vaccin protégeant 

du COVID-19. La meilleure façon de vous 

protéger est d’éviter de vous exposer au virus 

causant le COVID-19.

• Restez à la maison autant que vous le 

pouvez et évitez le contact rapproché avec 

d’autres personnes.

• Couvrez-vous la bouche et le nez avec un linge 

en tissu lorsque vous êtes dans un lieu public

• Nettoyez et désinfectez fréquemment

les surfaces touchées.

• Lavez-vous régulièrement les mains à l’eau et 

au savon pendant au moins 20 secondes, ou 

utilisez un désinfectant à base d’alcool pour les 

mains contenant au moins 60 % d’alcool.

milk

Pratiquez la distanciation sociale

• Faites vos courses, commandez 

vos médicaments, communiquez 

avec votre médecin et effectuez 

vos activités bancaires en ligne 

autant que possible.

• Si vous devez vous rendre 

quelque part en personne, restez 

à au moins 2 mètres des autres 

et désinfectez les objets que 

vous touchez.

• Faites-vous livrer, achetez à 

emporter et limitez le contact 

physique autant que possible. 

Évitez de propager le COVID-19 si 

vous êtes malade

• Si vous êtes malade, restez chez 

vous et ne sortez que pour 

obtenir des soins médicaux.

• Évitez les transports en 

communs, le covoiturage et 

les taxis.

• Tenez-vous éloigné(e) des autres 

personnes et des animaux 

présents chez vous. 

• Il n’existe pas de traitement 

spécifique contre le COVID-19, 

mais vous pouvez consultez un 

médecin pour aider à atténuer 

vos symptômes.

• Si vous avez besoin de voir un 

médecin, appelez à l’avance.

Connaissez votre risque de

maladie grave

• Chacun(e) risque de contracter le 

COVID-19.

• Les personnes plus âgées, ainsi 

que les personnes de tout âge 

souffrant de pathologies sousjacentes graves, peuvent avoir 

un risque plus élevé de souffrir 

d’une maladie plus sévère.
# Mutual fund filings containing a risk/return summary tagged using the US Mutual Fund Risk/Return Taxonomy.

This is a list of up to 200 of the latest filings containing a risk/return summary tagged using the US Mutual Fund Risk/Return Taxonomy, updated every 10 minutes.

- Tidal Trust II (0001924868) (Filer) 485BPOS
- Tidal ETF Trust (0001742912) (Filer) 497
# APPENDIX U

List of

# EPA Regional WaterQuality StandardsCoordinators



# WATERQUALITY STANDARDS HANDBOOK

SECONDEDITION

# WATER QUALITY STANDARDS

COORDINATORS

Eric Hall, WQS Coordinator Larry Shepard, WQS Coordinator EPA Region 1 EPA Region 7 Water Division Water Complainance Branch JFK Federal Building 726 Minnesota Avenue Boston, MA 02203 Kansas City, KS 66101 617-565-3533 913-551-7441

Wayne Jackson, WQS Coordinator EPA Region 2 Water Division 26 Federal Plaza New York, NY 10278 212-264-5685 Bill Wuertherle, WQS Coordinator EPA Region 8 Water Division 999 18thStreet Denver, CO 80202-2405 303-293-1586

Evelyn MacKnight, WQS Coordinator EPA Region 3 Water Division 841 Chestnut Street Philadelphia, PA 19107 215-597-4491 Phil Woods, WQS Coordinator EPA Region 9 Water Division 75 Hawthorne Street SanFrancisco, CA 94105 415-744-1997

Fritz Wagener, WQS Coordinator EPA Region 4 Water Division 345 Courtland Street, N.E. Atlanta, GA 30365 404-347-3555x6633 Marcia Lagerloef, WQS Coordinator EPA Region 10 Water Division (WS-139) 1200 Sixth Avenue Seattle, WA 98101 206-553-0176

David Pfeifer, WQS Coordinator EPA Region 5 Water Division 77West Jackson Boulevard Chicago, IL 60604-3507 312-353-9024
Cheryl Overstreet, WQS Coordinator EPA Region 6 Water Division 1445 RossAvenue First Interstate Bank Tower Dallas, TX 75202 214-655-6643 -orSally Brough, WQS Coordinator EPA Region 10 Water Division (WS-139) 1200 Sixth Avenue Seattle. WA 98101 206-553-1754

(8/15/94) * US. GOVERNMENT PRINTING OFFICE: 1994-381-683

# APPENDIX V

WaterQuality StandardsProgram DocumentRequestForms



# WATERQUALITY STANDARDS HANDBOOK

SECONDEDITION
#### In the Matter of the Arbitration Between Samuel Ackerman et al., Doing Business as Ackerman and Davidson, Appellants, and Camden Textile Corporation, Respondent, and “John” Downey et al., Doing Business as Downey & Domidion.

No opinion. Settle order on notice. Present — Martin, P. J., Townley, Glennon, Untermyer and Dore, JJ,
MP 315822-A 2020年7月1日

cdc.gov/coronavirus

如果您可能感染或确诊感染COVID-19:

6. 咳嗽和打喷嚏时用纸巾

遮住或用手肘内侧挡住。

2. 密切监控个人症状。

如果症状加重,请立即

联系医疗保健人员。

4. 如有预约,请提前打

电话给您的医疗服

务提供者,告知他们

您已感染或可能已感

染COVID-19。

7. 常洗手用肥皂和清水洗手

至少20秒,或使用酒精含

量不低于60%的免洗消毒

液清洁双手。 

8. 尽量自我隔离,避免与

他人接触。如果可以的话,

请使用单独的浴室。

如需要与人群接触或出门,

请戴好口罩。

1. 居家隔离,避免外出工

作和学习。避免前往其他

公共场所。如果必须外出,

请尽量不要乘坐公共交通

工具,比如共享单车、

出租车等。

9. 避免与家中成员共用

私人物品,例如餐具,

毛巾和床上用品。

3. 保证足够的休息和

饮水。 

10. 清洁所有经常触摸的

物体表面,例如柜台、

桌面和门把手。按说明书

使用家庭清洁喷雾或擦试

剂。

5. 如有紧急情况,请拨

打911并告知接洽人

员您已感染或可能已

感染COVID-19。

居家管理COVID-19

症状要做的10件事

可访问版本:https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.html

911
### §429a. Jurisdiction and control; authorization of annual appropriation

Each parcel of land acquired under section 429 of this title shall be under the jurisdiction and control of the Secretary of the Interior, and there is authorized to be appropriated for the maintenance of each such parcel of land, fence, approach, and marker a sum not to exceed $250 per annum.

(Feb. 21, 1929, ch. 289, §3, 45 Stat. 1254; Ex. Ord. No. 6166, §2, June 10, 1933; Ex. Ord. No. 6228, §1, July 28, 1933.)

#### **Executive Documents**

#### Transfer of Functions

"Secretary of the Interior" substituted in text for "Secretary of War" pursuant to Reorg. Plan No. 3 of 1950, §§1, 2; Ex. Ord. No. 6166, §2; and Ex. Ord. No. 6228, §1. See below.

Reorg. Plan No. 3 of 1950, §§1, 2, eff. May 24, 1950, 15 F.R. 3174, 64 Stat. 1262, set out in the Appendix to Title 5, Government Organization and Employees, transferred the functions of other officers, employees, and agencies of the Department of the Interior, with certain exceptions, to the Secretary of the Interior, with power to delegate.

Ex. Ord. No. 6166, §2, and Ex. Ord. No. 6228, §1, set out as a note under section 901 of Title 5, transferred the administrative functions of Brices Cross Roads and Tupelo battlefield sites to the Department of the Interior.
§ 51.55 Consistency with constitutional and statutory requirements. ( a ) *Consideration in general.* In making a determination under section 5, the Attorney General will consider whether the change neither has the purpose nor will have the effect of denying or abridging the right to vote on account of race, color, or membership in a language minority group in light of, and with particular attention being given to, the requirements of the 14th, 15th, and 24th Amendments to the Constitution, 42 U.S.C. 1971(a) and (b), sections 2, 4(a), 4(f)(2), 4(f)(4), 201, 203(c), and 208 of the Act, and other constitutional and statutory provisions designed to safeguard the right to vote from denial or abridgment on account of race, color, or membership in a language minority group.
( b ) *Section 2.* Preclearance under section 5 of a voting change will not preclude any legal action under section 2 by the Attorney General if implementation of the change demonstrates that such action is appropriate.
[52 FR 490, Jan. 6, 1987, as amended at 63 FR 24109, May 1, 1998; Order No. 3262-2011, 76 FR 21249, Apr. 15, 2011]
III 

116TH CONGRESS 

1ST SESSION S. RES. 276 

Designating July 15, 2019, as ‘‘National Leiomyosarcoma Awareness Day’’ 

and the month of July 2019 as ‘‘National Sarcoma Awareness Month’’. 

IN THE SENATE OF THE UNITED STATES 

JULY 15, 2019 

Ms. STABENOW submitted the following resolution; which was referred to the 

Committee on the Judiciary 

RESOLUTION 

Designating July 15, 2019, as ‘‘National Leiomyosarcoma 

Awareness Day’’ and the month of July 2019 as ‘‘National Sarcoma Awareness Month’’. 

Whereas sarcoma is a rare type of cancer that arises in the 

connective tissue of the body and accounts for approximately 1 percent of all newly diagnosed cancers; 

Whereas the National Institutes of Health designates sarcoma as a rare form of cancer, and sarcoma contains approximately 70 different subtypes; 

Whereas sarcomas are largely resistant to current chemotherapy agents, immunotherapy agents, and radiation 

therapies, posing a formidable challenge for researchers 

and specialists; 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•SRES 276 IS 

Whereas sarcoma subtypes largely have not benefitted from 

immunotherapies because of the complexity of the DNA, 

genomes, and mutations associated with the many variations in the sarcoma subtype landscape; 

Whereas leiomyosarcoma (referred to in this preamble as 

‘‘LMS’’) is a malignant, aggressive subtype of sarcoma 

derived from smooth muscle cells typically of uterine, gastrointestinal, or soft tissue origin, and can metastasize to 

the bone, spine, brain, and liver; 

Whereas the National Institutes of Health classifies LMS as 

a rare disease, accounting for approximately 15 percent 

of all sarcomas, and LMS itself encompasses at least 4 

different LMS subtypes; 

Whereas LMS primarily affects adults without regard to gender, research and clinical trials remain complicated, and 

survival and longevity remain difficult; 

Whereas multidisciplinary care coordination teams, because 

of their expertise and experience, are critical to the 

health of sarcoma and LMS patients; 

Whereas sarcoma and LMS research will allow medical professionals to improve the quality of care for affected patients, lead to better clinical outcomes, and promote 

longer survival for patients; and 

Whereas increased education and awareness about sarcoma 

and LMS will contribute to the well-being of the communities of the United States: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates July 15, 2019, as ‘‘National 

3 Leiomyosarcoma Awareness Day’’; 


pamtmann on DSKBFK8HB2PROD with BILLS
3 

•SRES 276 IS 

1 (2) designates the month of July 2019 as ‘‘Na2 tional Sarcoma Awareness Month’’; 

3 (3) recognizes the challenges faced by sarcoma 

4 and leiomyosarcoma patients; and 

5 (4) commends the dedication of organizations, 

6 volunteers, researchers, and caregivers across the 

7 country working to improve the quality of life of sar8 coma and leiomyosarcoma patients and their fami9 lies. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS